Neuregulin-1 suppresses muscarinic receptor expression and acetylcholine-activated muscarinic K+ channels in cardiac myocytes. 2003

Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
Department of Anatomy and Neurobiology, Morehouse School of Medicine, 720 Westview Drive, SW, MRC 223, Atlanta, GA 30310, USA. BFord@msm.edu

The neuregulin-1 family of growth factors regulates nicotinic acetylcholine receptor synthesis in skeletal muscle, but its role in cardiac myogenesis remains unclear. Here, we investigate the involvement of neuregulins in the development of cardiac cholinergic responsiveness. Treatment of chick cardiac myocytes with neuregulin-1 inhibited mRNA expression of the M4 muscarinic receptor, but not the M2 receptor. In addition, mRNA levels of GIRK1 were reduced in myocytes by treatment with neuregulin-1. Activation of cholinergic receptors in cultured chick atrial myocytes by carbachol produced an outward potassium current (I(K(ACh))), which was attenuated by 24-48-h pre-treatment with neuregulin-1. These data suggest that neuregulins can regulate cardiac parasympathetic tone and may be involved in the pathogenesis of cardiac arrhythmias and heart failure.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015221 Potassium Channels Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits. Ion Channels, Potassium,Ion Channel, Potassium,Potassium Channel,Potassium Ion Channels,Channel, Potassium,Channel, Potassium Ion,Channels, Potassium,Channels, Potassium Ion,Potassium Ion Channel
D043588 Receptor, Muscarinic M4 A specific subtype of muscarinic receptor found in the CORPUS STRIATUM and the LUNG. It has similar receptor binding specificities to MUSCARINIC RECEPTOR M1 and MUSCARINIC RECEPTOR M2. Muscarinic Receptor M4,Muscarinic Receptors M4,Receptors, Muscarinic M4,M4 Receptor, Muscarinic,M4 Receptors, Muscarinic,M4, Muscarinic Receptor,M4, Muscarinic Receptors,Muscarinic M4 Receptor,Muscarinic M4 Receptors,Receptor M4, Muscarinic,Receptors M4, Muscarinic
D020133 Reverse Transcriptase Polymerase Chain Reaction A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols. Polymerase Chain Reaction, Reverse Transcriptase,Reverse Transcriptase PCR,PCR, Reverse Transcriptase,Transcriptase PCR, Reverse
D020890 Neuregulin-1 A peptide factor originally identified by its ability to stimulate the phosphorylation the erbB-2 receptor (RECEPTOR, ERBB-2). It is a ligand for the erbB-3 receptor (RECEPTOR, ERBB-3) and the erbB-4 receptor. Variant forms of NEUREGULIN-1 occur through alternative splicing of its mRNA. Glial Growth Factor,Heregulin,NDF Protein,NRG1 Protein,neu Differentiation Factor,GGF Protein,Differentiation Factor, neu,Neuregulin 1

Related Publications

Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
May 1994, The American journal of physiology,
Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
January 1998, The Journal of pharmacology and experimental therapeutics,
Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
September 2006, British journal of pharmacology,
Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
April 2000, The Journal of pharmacology and experimental therapeutics,
Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
September 1989, The American journal of physiology,
Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
July 2012, Biochemical and biophysical research communications,
Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
June 2007, European journal of pharmacology,
Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
July 1997, The Journal of biological chemistry,
Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
November 2005, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Byron D Ford, and Yun Liu, and Mary Anne Mann, and Raul Krauss, and Kiwita Phillips, and Li Gan, and Gerald D Fischbach
September 1990, Nature,
Copied contents to your clipboard!